BioSpace News Archive

BioLineRx announced today that Genentech has commenced a Phase 1b/2 study for the treatment of gastric cancer with BL-8040 in combination with atezolizumab, Genentech’s anti-PDL1 cancer immunotherapy agent.

Merck announced the presentation of updated overall survival (OS) findings, a secondary endpoint, from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA (pembrolizumab).

Episona announced today that it is entering the consumer market with the first at-home, epigenetics-based test for evaluating male infertility.

“Q” Bentley, a canine patient of Bush Veterinary Neurology Service (BVNS), has had a remarkable response to treatment of a glioma brain tumor. The treatment was performed through a clinical trial at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, funded by the National Institutes of Health.

Third-quarter worldwide sales of $6.8 billion increased 28.8% in Q3.

Haemonetics announced the election of Robert E. Abernathy to its Board of Directors.

On August 2, 2017, an American surgical team conducted a surgery to replace the sternum and partial ribcage of a 20 year-old woman using a custom 3D-printed composite titanium/porous polyethylene implant. It is the first time this technology has been used in the United States and only the second time in the world that a 3D-printed composite sternum and ribcage has been implanted.

Biocept announces the launch of its molecular pathology partnership initiative, the aim of which is to incorporate community pathologists into the review of biomarkers found in liquid biopsy for patients diagnosed with cancer.

SCORR Marketing, a global health science marketing and communications firm, and Applied Clinical Trials have released a new study, Collaborative R&D Survey Report.

Freenome announced the formation of its Scientific Advisory Board (SAB) comprised of leading experts in genomics and machine learning.